Skip to content

Pain Sensitivity and Psychological Profile of Chronic Low Back Pain Patients

Pain Sensitivity and Psychological Profile of Chronic Low Back Pain Patients: Implications for a Personalized Treatment Approach

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04879394
Enrollment
160
Registered
2021-05-10
Start date
2022-05-16
Completion date
2023-12-31
Last updated
2022-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Brief summary

This study aims to characterize pain sensitivity and psychological profile of CLBP patients in comparison with pain free adults, and explore their predictive role on hypnosis outcomes, an effective intervention for pain control.

Detailed description

Chronic low back pain (CLBP) is a very prevalent condition, associated with high disability and financial costs. Pain sensitization and psychological status have been associated with symptom severity and treatment outcomes, but their prognostic value is not yet well established. This is a Prospective Randomized Controlled Trial, with an experimental (hypnosis) and one control group (standard care), and 5 assessment points: baseline, post intervention, 1, 3 and 6 months follow-up. Participants will be 160 CLBP patients and 50 pain free adults, assessed on sociodemographic, clinical, pain, disability, psychophysical (Quantitative Sensory Testing) and psychological variables. This work will contribute to a better knowledge of the mechanisms underlying CLBP and of the patient characteristics that can predict treatment outcomes after hypnosis. The findings have the potential to improve patient-targeted treatment approaches.

Interventions

OTHERHypnosis

4 weekly hypnosis sessions, aiming at pain control and distress management. The 90 min. sessions will be conducted in group format by a doctorate-level psychologist trained in hypnosis. Contents will be detailed on hypnosis protocols to ensure standardization.

Sponsors

Hospital de Braga
CollaboratorOTHER
Clinical Academic Center (2CA-Braga)
CollaboratorOTHER
University of Minho
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* persistent or recurrent low back pain lasting over 3 months

Exclusion criteria

* pain due to other causes (e.g. fibromyalgia, fracture) * back surgery in the previous 6 months or planned in the following 6 months * debilitating organic, psychiatric or neurological conditions (e.g. cancer, schizophrenia, dementia) * disability compensation or litigation related to CLBP * unavailability to commit to the hypnosis sessions.

Design outcomes

Primary

MeasureTime frameDescription
Pain intensity at 1 week as assessed by Numeric Rating Scale (NRS)1 week post-interventionPain intensity assessed by NRS
Pain intensity at 1 month as assessed by NRS1 month post-interventionPain intensity assessed by NRS
Pain intensity at 3 months as assessed by NRS3 months post-interventionPain intensity assessed by NRS
Pain intensity at 6 months as assessed by NRS6 months post-interventionPain intensity assessed by NRS

Secondary

MeasureTime frameDescription
Functionality at 1 week as assessed by the Oswestry Low Back Pain Disability Questionnaire (ODI)1 week post-interventionFunctionality assessed by the ODI
Functionality at 1 month as assessed by the ODI1 month post-interventionFunctionality as assessed by the ODI
Functionality at 3 months as assessed by the ODI3 months post-interventionFunctionality assessed by the ODI
Functionality at 6 months as assessed by the ODI6 months post-interventionFunctionality assessed by the ODI
Quality of life at 1 week as assessed by the EuroQol Quality of Life Questionnaire (EQ-5D-5L)1 week post-interventionQuality of life assessed by the EQ-5D-5L
Quality of life at 1 month as assessed by the EQ-5D-5L1 month post-interventionQuality of life assessed by the EQ-5D-5L
Quality of life at 3 months as assessed by the EQ-5D-5L3 months post-interventionQuality of life assessed by the EQ-5D-5L
Quality of life at 6 months as assessed by the EQ-5D-5L6 months post-interventionQuality of life assessed by the EQ-5D-5L
Emotional distress at 1 week as assessed by the Hospital Anxiety and Depression Scale (HADS)1 week post-interventionEmotional distress assessed by HADS
Emotional distress at 1 month as assessed by the Hospital Anxiety and Depression Scale (HADS)1 month post-interventionEmotional distress assessed by HADS
Pain interference at 1 week as assessed by the Brief Pain Inventory (BPI)1 week post-interventionPain interference assessed by the BPI
Emotional distress at 6 months as assessed by the Hospital Anxiety and Depression Scale (HADS)6 months post-interventionEmotional distress assessed by HADS
Optimism at 1 week as assessed by the Life Orientation Test (LOT)1 week post-interventionOptimism assessed by LOT
Optimism at 1 month as assessed by LOT1 month post-interventionOptimism assessed by LOT
Optimism at 3 months as assessed by LOT3 months post-interventionOptimism assessed by LOT
Optimism at 6 months as assessed by LOT6 months post-interventionOptimism assessed by LOT
Pain catastrophizing at 1 week as assessed by the Pain Catastrophizing Scale (PCS)1 week post-interventionPain catastrophizing assessed by PCS
Pain catastrophizing at 1 month as assessed by PCS1 month post-interventionPain catastrophizing assessed by PCS
Pain catastrophizing at 3 months as assessed by PCS3 months post-interventionPain catastrophizing assessed by PCS
Pain catastrophizing at 6 months as assessed by PCS6 months post-interventionPain catastrophizing assessed by PCS
Emotional distress at 3 months as assessed by the Hospital Anxiety and Depression Scale (HADS)3 months post-interventionEmotional distress assessed by HADS
Pain interference at 1 month as assessed by the BPI1 month post-interventionPain interference assessed by the BPI
Pain interference at 3 months as assessed by the BPI3 months post-interventionPain interference assessed by the BPI
Pain interference at 6 months as assessed by the BPI6 months post-interventionPain interference assessed by the BPI

Countries

Portugal

Contacts

Primary ContactPatrícia R Pinto, PhD
patipinto@gmail.com00351253604926

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026